Social Cognition Assessment and Rehabilitation for Families living with Brain Tumour (SCARF-BT): a feasibility study

Overview

Phase: 未知
Intervention: Not specified
Conditions: Defects of emotional recognition in brain tumour (glioblastoma) patients
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Enrollment: 60
Status: Active, not recruiting
Last Updated: 3 years ago

No summary available.

Registry

who.int

Start Date

April 30, 2021

End Date

March 31, 2024

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\. Patients pre\-screened as part of the CogENT and SIND studies, scoring 11 or less on the emotional recognition test within the OCS\-Bridge screening tool done pre\-operatively (consistent with having a deficit pre\-operatively)
•2\. Signed Informed Consent to SCARF\-BT study
•3\. Aged 18 years and older
•4\. Imaging evidence of a high\-grade glioma as assessed by a neuro\-oncology MDT
•5\. MDT and treating clinician recommend either biopsy or debulking of the tumour; 6\. Patients scoring 11 or less on the emotional recognition test within the OCS\-Bridge screening tool done post\-operatively (consistent with having a deficit post\-operatively)
•7\. Patients with WHO Performance status 0\-2
•8\. Patients suitable for oncological intervention (involving radiotherapy/ chemotherapy/ combining radiotherapy and chemotherapy)
•9\. For Qualitative Study only: speaks fluent English as the use of interpreters can alter patients exact words
•10\. For Qualitative Study only: willing to participate in the interviews and/or focus groups
•1\. Written informed consent

•1\. Patients unable to give written consent or who lack capacity to consent
•2\. Patients for palliative/best supportive care only, following surgery
•3\. Pre\-morbid developmental or acquired/traumatic neurologic disorder (e.g. autism, stroke, severe head injury or dementia/cognitive impairment)
•4\. Pre\-morbid major psychiatric disorder (e.g., schizophrenia)
•Impaired vision and/or hearing that would interfere with task participation (determined by interacting with participant on screening and medical history)
•5\. Patients have impairment of facial recognition (i.e. prosopagnosia) using the OCS\-Bridge screening tool score of \>5 on immediate assessment
•6\. Impaired facial recognition (i.e. prosopagnosia) using a separate test from the OCS\-Bridge screening tool, where a score of \=5 on immediate assessment of neutral face recognition would suggest a deficit requiring exclusion